Randomized Controlled Trial: Subcutaneous vs Intravenous Infliximab CT-P13 Maintenance in Inflammatory Bowel Disease
2021 · Gastroenterology · 216 citations
https://doi.org/10.1053/j.gastro.2021.02.068
S
Seul Gi Lee
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
47
Papers
866
Citations
15
h-index
21
i10-index
Seul Gi Lee is an academic researcher. The author has contributed to research in topics: Thyroid Cancer Diagnosis and Treatment & Thyroid and Parathyroid Surgery & Crystallization and Solubility Studies. The author has an h-index of 15, co-authored 40 publications.
ORCID: 0000-0002-6461-535XPapers by this author
worksTransaxillary robotic modified radical neck dissection: a 5-year assessment of operative and oncologic outcomes
2016 · Surgical Endoscopy · 51 citations
https://doi.org/10.1007/s00464-016-5146-9
Doping behavior of Br in Li4Ti5O12 anode materials and their electrochemical performance for Li-ion batteries
2019 · Ceramics International · 27 citations
https://doi.org/10.1016/j.ceramint.2019.05.322
Non-genomic activation of the AKT-mTOR pathway by the mitochondrial stress response in thyroid cancer
2022 · Oncogene · 9 citations
https://doi.org/10.1038/s41388-022-02484-7
Su1762 SUBCUTANEOUS INFLIXIMAB (CT-P13 SC) AS MAINTENANCE THERAPY FOR CROHN'S DISEASE: 2 YEARS RESULTS OF THE LIBERTY-CD STUDY
2024 · Gastroenterology · 0 citations
https://doi.org/10.1016/s0016-5085(24)02326-6
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat